Evidence map›Paper›PMID 35710609›Full record

ArticleNature methods2022

Mass spectrometry-based draft of the mouse proteome.

Piero Giansanti, Patroklos Samaras, Yangyang Bian, Chen Meng, Andrea Coluccio, Martin Frejno, Hannah Jakubowsky, Sophie Dobiasch, Rashmi R Hazarika, Julia Rechenberger and 21 more

Abstract read
In one paragraph

Article in Nature methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Brain Proteomic Responses to Glucocorticoids and Their Relationship With Transcriptome: A Systematic Meta-Analysis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

Piero Giansanti *Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0003-2857-0841
Patroklos Samaras *Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0001-6042-1585
Yangyang Bian *Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-9909-1699
Chen MengBavarian Biomolecular Mass Spectrometry Center, Technical University of Munich, Freising, Germany.
Andrea ColuccioDivision of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Martin FrejnoChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-6651-1773
Hannah JakubowskyDivision of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Sophie DobiaschDepartment of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Rashmi R HazarikaPopulation epigenetics and epigenomics, Technical University of Munich, Freising, Germany.
Julia RechenbergerChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0003-4189-3434
Julia Calzada-WackInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Johannes KrummChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Sebastian MuellerDepartment of Internal Medicine II, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Chien-Yun LeeChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0001-7697-6374
Nicole WimbergerDivision of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-9799-8983
Ludwig LautenbacherChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-1540-5911
Zonera HassanMedical Clinic and Policlinic II, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Yun-Chien ChangChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Chiara FalcomatàDivision of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Florian P BayerChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Stefanie BärthelDivision of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-5986-4864
Tobias SchmidtChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-1883-6514
Roland RadDivision of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Stephanie E CombsDepartment of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Matthew TheChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Frank JohannesPopulation epigenetics and epigenomics, Technical University of Munich, Freising, Germany.
Dieter SaurDivision of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-5874-0210
Martin Hrabe de AngelisInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-7898-2353
Mathias WilhelmChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-9224-3258
Günter SchneiderMedical Clinic and Policlinic II, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-1840-4508
Bernhard KusterChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany. kuster@tum.de.ORCID http://orcid.org/0000-0002-9094-1677

Funding

European Research Council 833710
6 · The paper itself

Abstract

The laboratory mouse ranks among the most important experimental systems for biomedical research and molecular reference maps of such models are essential informational tools. Here, we present a quantitative draft of the mouse proteome and phosphoproteome constructed from 41 healthy tissues and several lines of analyses exemplify which insights can be gleaned from the data. For instance, tissue- and cell-type resolved profiles provide protein evidence for the expression of 17,000 genes, thousands of isoforms and 50,000 phosphorylation sites in vivo. Proteogenomic comparison of mouse, human and Arabidopsis reveal common and distinct mechanisms of gene expression regulation and, despite many similarities, numerous differentially abundant orthologs that likely serve species-specific functions. We leverage the mouse proteome by integrating phenotypic drug (n > 400) and radiation response data with the proteomes of 66 pancreatic ductal adenocarcinoma (PDAC) cell lines to reveal molecular markers for sensitivity and resistance. This unique atlas complements other molecular resources for the mouse and can be explored online via ProteomicsDB and PACiFIC.

Indexed as

ArabidopsisCarcinoma, Pancreatic DuctalPancreatic NeoplasmsAnimalsMass SpectrometryMiceProteomeProteome

Identifiers

PMID35710609
PMCPMC7613032

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.